Cite
HARVARD Citation
Jonczak, S. et al. (2022). Inflammatory Myofibroblastic Tumor Refractory to Three Lines of ALK Inhibitors and Combination Immunotherapy. International journal of clinical and medical cases. 5 (2), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Jonczak, S. et al. (2022). Inflammatory Myofibroblastic Tumor Refractory to Three Lines of ALK Inhibitors and Combination Immunotherapy. International journal of clinical and medical cases. 5 (2), p. . [Online].